Document is current
Any future updates will be listed below
-
Authors
Li, Hui
Zhang, Mingming
Wei, Yanli
Haider, Farhan
Lin, Yitong
Guan, Wen
Liu, Yanbin
Zhang, Shaoyang
Yuan, Ronghua
Yang, Xia
Yang, Shulan
Wang, Haihe
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81672704)
National Natural Science Foundation of China (81171947)
International Collaboration Project of Natural Science Foundation of Guangdong Province (2014A050503030)
Guandong Science and Technology Project (2015B090903063)
- License Information
-
More Information
Article History
Received: 25 November 2019
Accepted: 22 April 2020
First Online: 7 May 2020
Ethics approval and consent to participate
: The research was approved by the Ethics Committee of Sun Yat-Sen University.
: All subjects have written informed consent.
: Drs. Haihe Wang and Shulan Yang, researchers on the study team, are co-inventors on Patent 201710512823.6 (Sun Yat-sen University) which deals with the application of SH3BGRL as a diagnostic and therapy target. No other authors have competing interests.
